Stay updated on ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial
Sign up to get notified when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.

Latest updates to the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ORION-3 results section has been updated to include long-term efficacy and safety data, with LDL-C changes over time and adverse events across treatment arms. This update reflects the four-year open-label extension of ORION-1 and the associated extended follow-up results.SummaryDifference0.0%

- Check17 days agoChange DetectedNo significant additions or deletions were detected on the page; the study results information and layout appear unchanged.SummaryDifference0.0%

- Check41 days agoChange DetectedVersion bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.0%

- Check55 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed; no other substantive content changes were detected.SummaryDifference0.0%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.0%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a new reference to a study on inclisiran, while several location-related terms have been removed.SummaryDifference0.7%

Stay in the know with updates to ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.